MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group

Rachel S. van Leeuwaarde, Koen M. Dreijerink, Margreet G. Ausems, Hanneke J. Beijers, Olaf M. Dekkers, Wouter W. de Herder, Anouk N. van der Horst-Schrivers, Madeleine L. Drent, Peter H. Bisschop, Bas Havekes, Petra H. M. Peeters, Ruud M. Pijnappel, Menno R. Vriens, Gerlof D. Valk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2083-2090
Number of pages8
JournalJournal of Clinical Endocrinology & Metabolism
Volume102
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • ENDOCRINE NEOPLASIA TYPE-1
  • BRCA2 MUTATION CARRIERS
  • SELECTION BIAS
  • RISK
  • BENEFITS
  • SMOKING
  • HARMS
  • NONCARRIERS
  • PENETRANCE
  • MORTALITY

Cite this

van Leeuwaarde, R. S., Dreijerink, K. M., Ausems, M. G., Beijers, H. J., Dekkers, O. M., de Herder, W. W., van der Horst-Schrivers, A. N., Drent, M. L., Bisschop, P. H., Havekes, B., Peeters, P. H. M., Pijnappel, R. M., Vriens, M. R., & Valk, G. D. (2017). MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group. Journal of Clinical Endocrinology & Metabolism, 102(6), 2083-2090. https://doi.org/10.1210/jc.2016-3690